Trials / Conditions / Endometrial Squamous Cell Carcinoma
Endometrial Squamous Cell Carcinoma
6 registered clinical trials studyying Endometrial Squamous Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer NCT01642082 | Gynecologic Oncology Group | Phase 2 |
| Completed | Nintedanib in Treating Patients With Recurrent or Persistent Endometrial Cancer NCT01225887 | Gynecologic Oncology Group | Phase 2 |
| Completed | Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer NCT01440998 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer NCT00888173 | Gynecologic Oncology Group | Phase 2 |
| Unknown | Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer NCT00492778 | GOG Foundation | Phase 2 |
| Completed | Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV En NCT00575952 | Gynecologic Oncology Group | Phase 1 |